Your browser doesn't support javascript.
loading
Predicting response of ischemic central retinal vein occlusion to bevacizumab injections: 1 year follow-up.
Segal, Ori; Mimouni, Michael; Rabina, Gilad; Yavnieli, Roy; Nemet, Arie Y.
Afiliación
  • Segal O; Department of Ophthalmology, Meir Medical Center, Kfar Sava and the Sackler School of Medicine, Tel Aviv University, Kfar Saba, 44281, Israel. orisegal@gmail.com.
  • Mimouni M; Department of Ophthalmology, Rambam Health Care Campus and the Technion-Israel Institute of Technology, Haifa, Israel.
  • Rabina G; Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Yavnieli R; Department of Ophthalmology, Rambam Health Care Campus and the Technion-Israel Institute of Technology, Haifa, Israel.
  • Nemet AY; Department of Ophthalmology, Meir Medical Center, Kfar Sava and the Sackler School of Medicine, Tel Aviv University, Kfar Saba, 44281, Israel.
Int Ophthalmol ; 41(2): 533-540, 2021 Feb.
Article en En | MEDLINE | ID: mdl-33094440

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oclusión de la Vena Retiniana / Edema Macular Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int Ophthalmol Año: 2021 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oclusión de la Vena Retiniana / Edema Macular Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int Ophthalmol Año: 2021 Tipo del documento: Article País de afiliación: Israel